“国人缺血性心血管病十年发病危险评估方法”在北京朝阳社区的应用

目的：探讨我国自行开发的＂国人缺血性心血管病10年发病危险度评估方法＂的临床应用价值。方法：采用中国医学科学院心血管病研究所开发的＂国人缺血性心血管病10年发病危险评估方法＂对北京朝阳区2465名社区居民的心血管病发病危险度进行评估,并进行相关分析。结果：（1）与女性组比较,男性组收缩压（122.84±16.42）mm-Hg∶（126.83±16.36）mmHg],舒张压（80.67±9.51）mmHg∶（84.54±9.89）mmHg]和总胆固醇（4.86±1.06）mmol/L∶（5.01±0.97）mmol/L]水平显著升高,P均〈0.001;（2）10年缺血性心血管病发病危险度≥10%者（高危者）所占的比例,男性为3.28%,显著高于女性的1.59%（P〈0.05）;这一结果与我国＂十五＂攻关课题组对9903名国人调查,随访15.1年缺血性心血管病绝对危险数据是一致的。结论：国人10年缺血性心血管病发病危险评估方法能较准确地检测人群的发病分布情况,有利于对高危人群的简单筛选。

Application of "Chinese evaluation method of 10-year morbid risk of ischemic cardiovascular diseases" in Chaoyang district of Beijing

Objective:To explore the clinical application value of"Chinese evaluation method of 10-year morbid risk of ischemic cardiovascular diseases"self developed from China.Methods:"Chinese evaluation method of 10-year motbid risk ofischemic cardiovascular diseases"developed bv cardiovascular diseaseinstitute of Chinese academy of medical science,was used to evaluate motbid risk of cardiovascular diseases of 2465 community residents in Chaoyang district of Beijing.Relative analysis was done then.Results:(1)Compared with female group,mean values of systolic blood pressure(122.84±16.42)mmHg vs.(126.83±16.36)mmHg],diastolic blood pressure(80.67±9.51) mmHg vs.(84.54±9.89)mmHg]and total cholesterol(4.86±1.06)mmol/L vs.(5.01±0.97)mmol/L]significantly increased in male group,P＜0.001 all;(2)For the ratio of subjects whose 10-year morbid risk of ischemic cardiovascular diseases≥10%(high risk subjects),was of 3.28% in men and significantly more than that of women(1.59%)P ＜0.05.It was consistent withthe data of absolute risk ofischemic cardiovascular diseasesfrom Chinese 9903 cases survey and follow up 15.1 years by the collaborative research group of the Chinese national 10th five years plan project.Conclusion:"Chinese evaluation method of 10-year morbid risk of ischemic cardiovascular diseases"can accurately detect distribution condition of morbid risk among population andit makeforto simple screening of high risk population.